Navigation Links
Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
Date:9/30/2010

VIENNA, Sept. 30 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that effective October 1, 2010, Staph Leavenworth Bakali will join its Management Board as Chief Business Officer with key responsibilities for the commercial aspects of the Company, directly leading Marketing and Sales, Corporate and Business Development, and Alliance Management. Staph will also play a key role with the other Management Board members in helping drive forward the Company's strategy. Prior to the appointment to Intercell AG's Management Board, Staph had stepped down from his position as member of the Supervisory Board of the company.

"Staph has an outstanding track record in the vaccines industry and has made major contributions to the success of some key vaccines businesses globally. His commercial and strategic experience ideally complement the skills of our current Management Board," said Gerd Zettlmeissl, Chief Executive Officer of Intercell AG. "We are proud to have Staph working with us towards the next growth phase of our Company."

"Having been a member of Intercell's Supervisory Board for almost five years, I have been impressed with the progress and capabilities of the Company and its people in creating value through innovation, industrialization and commercialization," said Staph Bakali. "I am delighted to join a very dynamic team and look forward to helping develop the business further."

Staph brings 20 years of vaccine industry experience from his previous leadership positions. He was recently Chief Executive Officer of Genocea Biosciences, a Boston (U.S.) based innovative biotech vaccine company, and previously Chief Operating Officer for ID Biomedical (Vancouver, Canada) and PowderJect (Oxford, UK), which were acquired by GlaxoSmithKline and Chiron, respectively. Staph Bakali was also previously head of Sales and Marketing for Chiron's global vaccine business and SmithKline Beecham's Vaccine Business Unit in France. Staph holds a Masters d
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
2. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
3. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
4. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
5. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
6. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
7. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
8. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
9. 3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer
10. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
11. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... PITTSBURGH , June 3, 2015 Mylan ... today announced that the Company will present at Goldman Sachs ... 9, 2015. The presentation is scheduled to begin at 4 ... parties can access a live webcast of the presentation via ... .   Mylan is a global pharmaceutical company ...
(Date:6/3/2015)... , June 3, 2015  NxStage Medical, Inc. (Nasdaq: ... dialysis products , today announced data that home ... 221 million gallons of water annually by transitioning ... to home hemodialysis with the NxStage® System One™.  ... 429 gallons of water per patient per week, ...
(Date:6/3/2015)... SEATTLE , June 3, 2015 ... acquire Northeast Pharmaceuticals, Inc., bringing together two pharmacy organizations ... with mental illness. Both companies have strong reputations for ... their customers. Genoa ... the behavioral health community and those affiliated with managing ...
Breaking Medicine Technology:Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2
... announced Phase 2b trial results for its investigational compound ... 30 to 40 percent in patients whose TG levels ... included an arm combining DCCR with fenofibrate treatment (Abbott ... was shown to be additive to fenofibrate for all ...
... HILL, N.C., Feb. 29, 2012  Cempra, Inc. (NASDAQ: ... Fernandes, Ph.D., president and chief executive officer, will present ... Conference at 11:20 a.m. EST, March 6, 2012, at ... will provide an overview of the company,s two leading ...
Cached Medicine Technology:Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 2Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 3Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2
(Date:6/3/2015)... California (PRWEB) June 03, 2015 ... biopharmaceuticals or biologics has revolutionized disease treatment on account ... cancer and autoimmune diseases, such as rheumatoid arthritis. The ... the use of traditional small molecule drugs to biopharmaceuticals ... monoclonal antibodies (mAbs), cell and gene therapies, and recombinant ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Dr. Steven ... York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, ... on weekdays to his practice. In most cases, depending on ... of the day they call, they will be seen by ... first priority as a cardiologist is to ensure that people ...
(Date:6/3/2015)... New York, NY (PRWEB) June 03, 2015 ... new strategic partnership to expand online and mobile ... including Board Review and Maintenance of Certification (MOC) ... Decker will market VeoMed’s innovative courses to Decker’s ... healthcare professionals interested in purchasing access to VeoMed’s ...
(Date:6/3/2015)... Z-Medica®, LLC, a leading developer and marketer ... designated as National Safety Month by the National Safety ... for its commitment to public safety. , The ... Aid Kits (IFAK) over 100 times in the past ... traffic accidents. Each kit is equipped with what’s needed ...
(Date:6/3/2015)... For the fourth time in less than ... full-service advertising agency, has been honored by a respected independent ... MCA has been selected as a Semi-Finalist for the 2015 ... honored at a luncheon sponsored by Adcock Financial Group and ... Art. , “This luncheon will include important information about the ...
Breaking Medicine News(10 mins):Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3
... Iraq, Afghanistan who sought medical care were victims , , ... the challenges facing women in the military, a new ... Iraq and Afghanistan veterans seeking VA medical care reported ... reported sexual trauma, such as rape and threatening sexual ...
... ), a leading provider of Manufacturing Process Intelligence software, announced ... and chief science officer, and Joe Rothman, Aegis’ vice president ... life sciences industry events in Germany and Spain. ... ...
... lung cancer called video-assisted thoracic surgery or VATS is ... centers. Now, a preliminary study to be presented ... is giving surgeons an early look at its benefits. ... a six to 10-inch incision, cutting the major muscles ...
... , Montreal, October 28, 2008 - Patients 80 years ... able to withstand open-heart surgery, according to the latest study ... (MUHC). His findings were presented this morning in Toronto during ... a reason for doctors to rule out the possibility of ...
... Compression Fracture Treatment Using Ultra-High Viscosity ... Oct. 28 DFine, Inc., a developer of,minimally ... secured a $30 million round of investment in ... and Highland Capital Management. Other investors,include Prospect Venture ...
... research study just published in,a major national journal reports ... over the last six years. But experts at U.S.,Preventive ... costs are far higher and that more can be ... people healthy., (Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO ), ...
Cached Medicine News:Health News:Sexual Trauma Haunts Many Female Vets 2Health News:Sexual Trauma Haunts Many Female Vets 3Health News: Aegis to Present on Global Stages : Company to Discuss How Manufacturing Process IntelligenceSupports Tech Transfer and Product Lifecycle Management 2Health News: Aegis to Present on Global Stages : Company to Discuss How Manufacturing Process IntelligenceSupports Tech Transfer and Product Lifecycle Management 3Health News:Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner 2Health News:DFine Secures $30 Million in Series D Funding 2Health News:U.S. Preventive Medicine Says Prevention Can Keep Diabetes Costs From Rising 2
... peripheral nerve stimulator automatically ... nerve locator or a ... upon which patient lead ... NSL-5 electrode lead set, ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
... Universal Hand Holder and Retractor Set ... hand in any position needed. Ball ... or tendon hooks, fixate the hand ... the patient's hand held firmly, the ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
Medicine Products: